🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases

Recruitingn/aAges 20 Years - 79 YearsAllMassachusetts General Hospital
NCT07780890 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The overall goal of this study is to develop Brillouin microscope as a novel tool for measuring biomechanical and hydration properties of human tissues in vivo.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Healthy volunteers with normal eyes * Visual acuity between +2 to -6 diopters Exclusion Criteria: * History of refractive or cataract surgery * History of ocular disease * Active non-ophthalmic systemic disease
💊

What it tests

  • Not listed
📍

Where

1 site
Massachusetts General Brigham
Boston, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy